Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
2,203 stocks worldwide match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| DYVOX.ST | Dynavox Group AB (publ) | Healthcare | $850.75M | 76.70 SEK | −41.76% | +4.14% |
| AHG | Akso Health Group | Healthcare | $848.14M | $0.99 | −60.40% | −32.19% |
| OXB.L | Oxford Biomedica plc | Healthcare | $847.14M | 515.00 GBP | −46.47% | −5.68% |
| PHAR | Pharming Group N.V. | Healthcare | $845.80M | $11.95 | −44.00% | −7.08% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| SLN | Silence Therapeutics plc | Healthcare | $840.94M | $13.53 | −23.02% | +17.14% |
| HSTM | HealthStream, Inc. | Healthcare | $840.94M | $28.76 | −7.55% | −0.31% |
| SFL.MI | Safilo Group S.p.A. | Healthcare | $839.99M | 1.85 EUR | −18.96% | +14.02% |
| AMS.L | Advanced Medical Solutions Group plc | Healthcare | $830.96M | 281.50 GBP | −1.05% | +0.36% |
| GNFT.PA | Genfit S.A. | Healthcare | $830.56M | 14.30 EUR | −5.92% | +5.30% |
| APOTEA.ST | Apotea AB (publ) | Healthcare | $822.73M | 75.30 SEK | −30.68% | +1.41% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | Healthcare | $819.46M | $3.18 | −23.92% | 0.00% |
| NVCT | Nuvectis Pharma, Inc. | Healthcare | $816.10M | $25.00 | −14.60% | +26.14% |
| EIQ.AX | Echo IQ Limited | Healthcare | $814.45M | 1.53 AUD | −18.67% | +21.03% |
| WELL.TO | WELL Health Technologies Corp. | Healthcare | $807.72M | 4.38 CAD | −27.96% | +9.23% |
| ARJO-B.ST | Arjo AB (publ) | Healthcare | $802.95M | 28.38 SEK | −21.95% | +4.11% |
| AURA | Aura Biosciences, Inc. | Healthcare | $801.64M | $7.73 | −18.93% | +9.65% |
| UU8.F | Neurogene Inc. | Healthcare | $795.50M | 33.20 EUR | −1.19% | +21.17% |
| STTK | Shattuck Labs, Inc. | Healthcare | $792.87M | $7.90 | −5.16% | +15.84% |
| VREX | Varex Imaging Corporation | Healthcare | $778.90M | $18.48 | −0.81% | +66.04% |
| SNT.WA | Synektik Spólka Akcyjna | Healthcare | $774.15M | 338.40 PLN | −15.06% | −5.58% |
| AHCO | AdaptHealth Corp. | Healthcare | $771.43M | $5.67 | −57.78% | −49.47% |
| NGNE | Neurogene Inc. | Healthcare | $768.64M | $38.41 | −12.02% | +15.62% |
| 001067.KS | JW Pharmaceutical Corporation | Healthcare | $766.24M | 46,100.00 KRW | −27.17% | +5.73% |
| MNPR | Monopar Therapeutics Inc. | Healthcare | $763.31M | $113.72 | −8.89% | +4.24% |
| 4588.T | Oncolys BioPharma Inc. | Healthcare | $753.78M | 4,080.00 JPY | −4.67% | +66.46% |
| DRUG | Bright Minds Biosciences Inc. | Healthcare | $751.90M | $76.63 | −38.08% | +6.49% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | Healthcare | $751.23M | $9.26 | −37.73% | +7.80% |
| D2OC34.SA | Doximity, Inc. | Healthcare | $733.94M | 21.20 BRL | −68.60% | +16.10% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | Healthcare | $730.42M | 3,290.00 JPY | −17.02% | +1.39% |
| SOPH | SOPHiA GENETICS SA | Healthcare | $726.14M | $8.53 | −3.62% | +53.14% |
| CTMX | CytomX Therapeutics, Inc. | Healthcare | $723.43M | $3.32 | −59.56% | +3.11% |
| ASMB | Assembly Biosciences, Inc. | Healthcare | $721.17M | $35.42 | −10.80% | +38.52% |
| OCS | Oculis Holding AG | Healthcare | $720.20M | $12.97 | −62.38% | +17.32% |
| PHR | Phreesia, Inc. | Healthcare | $716.58M | $11.60 | −64.59% | +6.81% |
| SSII | SS Innovations International, Inc. | Healthcare | $715.38M | $3.57 | −64.30% | −9.16% |
| DHT-UN.TO | DRI Healthcare Trust | Healthcare | $714.70M | 17.63 CAD | −10.73% | −0.51% |
| XOMA | XOMA Royalty Corp | Healthcare | $710.16M | $40.17 | −11.17% | 0.00% |
| PHAT | Phathom Pharmaceuticals, Inc. | Healthcare | $709.50M | $8.77 | −52.10% | −24.79% |
| IRWD | Ironwood Pharmaceuticals, Inc. | Healthcare | $708.88M | $4.29 | −25.78% | +12.89% |
| 9267.T | Genky DrugStores Co., Ltd. | Healthcare | $706.67M | 3,660.00 JPY | −32.97% | −11.91% |
| GYRE | Gyre Therapeutics, Inc. | Healthcare | $705.12M | $6.65 | −29.41% | +11.02% |
| ALLO | Allogene Therapeutics, Inc. | Healthcare | $704.80M | $2.04 | −54.26% | +22.89% |
| C2RS34.SA | CRISPR Therapeutics AG | Healthcare | $704.10M | 36.81 BRL | −29.42% | +20.41% |
| AGMB | AgomAb Therapeutics NV | Healthcare | $703.26M | $14.28 | −19.87% | +13.88% |
| TECX | Tectonic Therapeutic, Inc. | Healthcare | $703.19M | $35.97 | −9.01% | +20.70% |
| OABI | OmniAb, Inc. | Healthcare | $699.33M | $4.81 | −2.43% | +144.16% |
| ZVRA | Zevra Therapeutics, Inc. | Healthcare | $697.17M | $11.74 | −21.92% | +20.66% |
| EVT.DE | Evotec SE | Healthcare | $694.87M | 3.25 EUR | −55.42% | −6.22% |
| 7575.T | Japan Lifeline Co., Ltd. | Healthcare | $694.70M | 1,565.00 JPY | −4.86% | +7.93% |
| BHVN34.SA | BIOHAVEN LTDDRN | Healthcare | $694.68M | 23.68 BRL | −28.22% | 0.00% |
| PROK | ProKidney Corp. | Healthcare | $694.58M | $1.74 | −50.00% | +12.99% |
| EVO | Evotec SE | Healthcare | $693.01M | $1.95 | −54.33% | −0.51% |
| GMRS | GMR Solutions Inc. | Healthcare | $692.56M | $12.82 | −19.77% | −1.38% |
| GUD.TO | Knight Therapeutics Inc. | Healthcare | $690.78M | 9.76 CAD | −4.03% | −0.81% |
| DHT-U.TO | DRI Healthcare Trust | Healthcare | $690.34M | $12.56 | −9.25% | +0.88% |
| EIKN | Eikon Therapeutics, Inc. | Healthcare | $679.77M | $11.98 | −31.15% | +26.24% |
| AQST | Aquestive Therapeutics, Inc. | Healthcare | $676.51M | $5.39 | −28.61% | +43.35% |
| SGMT | Sagimet Biosciences Inc. | Healthcare | $675.04M | $10.86 | −2.60% | +49.38% |
| CBIO | Crescent Biopharma, Inc. | Healthcare | $669.39M | $18.02 | −34.26% | +9.61% |
| LBIRD.PA | Lumibird SA | Healthcare | $658.60M | 25.80 EUR | −10.10% | −1.53% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.